IP Library Granted Patent US 10,112,048
Granted Patent B2
US 10,112,048 · App. 15/676,910 · Granted Oct 30, 2018

Stimulation devices and methods for treating dry eye

Inventors: Manfred Franke (Valencia, CA); James Donald Loudin (Alhambra, CA); John Wardle (San Clemente, CA); Mark Jeffrey Holdbrook (Sunnyvale, CA)
Assignee: Oculeve, Inc.
A61N1/36046A61N1/0546A61N1/3606A61N1/3758A61N1/37205A61N1/37247A61N1/0526A61N1/36146A61N1/3756
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,112,048
App. No.
15/676,910
Granted
Oct 30, 2018
Kind
B2
Abstract

Described herein are devices and methods of use thereof for treating dry eye, tired eye, or other forms of ocular discomfort such as from contact lenses. The methods generally include applying spatially and/or temporally patterned stimulation to one or more anatomical structures located in an ocular or nasal region. The electrical stimulation may elicit a reflex that activates the lacrimal gland or may directly activate the lacrimal gland or nerves innervating the lacrimal gland to produce tears. The devices may be implantable or handheld, and may be configured to deliver the spatially and/or temporally patterned stimulation patterns described.

Claims (18)

1. A method for treating dry eye in a patient in need thereof, comprising:

contacting nasal mucosa of the patient with a first electrode; and

delivering current from the first electrode through tissue of the patient to a return contact,

wherein the first electrode is located on a nasal insertion prong of a stimulator probe of a stimulator, and the return contact is located on a stimulator body of the stimulator, and wherein the stimulator probe is reversibly attachable to the stimulator body.

2. The method of claim 1 , further comprising delivering current from the first electrode through tissue of the patient to a second electrode, wherein the second electrode is located on the nasal insertion prong.

3. The method of claim 2 , wherein current is delivered simultaneously from the first electrode to the return contact and from the first electrode to the second electrode.

4. The method of claim 3 , wherein the first electrode delivers a greater portion of current to the second electrode than to the return electrode.

5. The method of claim 2 , wherein the first electrode and the second electrode are spaced longitudinally along a length of the nasal insertion prong.

6. The method of claim 2 , wherein the first electrode and second electrode are spaced radially around a circumference of the nasal insertion prong.

7. The method of claim 2 , wherein the first electrode and second electrode are in contact with nasal mucosa on a first side of a septum of the patient.

8. The method of claim 1 , wherein the first electrode contacts nasal mucosa such that delivering current from the first electrode stimulates a nerve in the nasal mucosa.

9. The method of claim 8 , wherein the nerve is an anterior ethmoidal nerve.

10. The method of claim 1 , wherein the electrode comprises a hydrogel.

11. The method of claim 1 , wherein the stimulator probe is disposable, and the stimulator body is reusable.

12. The method of claim 1 , further comprising delivering current to nasal mucosa via a second nasal insertion prong.

13. The method of claim 1 , wherein the stimulator body comprises a user interface.

14. The method of claim 13 , wherein the user interface comprises one or more operating mechanisms to adjust one or more parameters of the current delivered.

15. The method of claim 1 , further comprising a detachable protective cap.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2017
From: FRANKE, MANFRED; LOUDIN, JAMES DONALD; WARDLE, JOHN; HOLDBROOK, MARK JEFFREY
To: OCULEVE, INC.
Reel/Frame 043553/0928 →
Continuity (3)
Division 14920860 · Oct 22, 2015
Provisional Application 62067416 · Oct 22, 2014
Related Publication 20170340884A1 · Nov 30, 2017
Cited By (5)
US 12,420,097 US 12,465,776 US 12,589,243 US 12,702,831 US 12,702,833